JT

John Taylor

Vice President of Business Development

Ribocure Pharmaceuticals

Ribocure Pharmaceuticals Pipeline

DrugIndicationPhase
UndisclosedRare diseases (Cardiovascular, Renal, Oncology)Phase 2